Prof. Dr. Peter Luppa

Peter B. Luppa, born April 5, 1955 in Amberg/Germany, is a Professor of Clinical Chemistry at the Technical University Munich (TUM), Germany. He was the executive senior physician of the core laboratory and head of the blood bank in the Institute of Clinical Chemistry and Pathobiochemistry at the Klinikum rechts der Isar (MRI), the academic hospital of the TUM. He acted also as POCT coordinator for the entire hospital. He retired in March 2024. Dr. Luppa received his Ph.D. 1980 from the University of Regensburg where he first studied chemistry. Then he studied medicine at the University of Erlangen-Nuerenberg and received the M.D. in 1986. Dr. Luppa was subsequently a fellow in the Postdoctoral Training Program in Clinical Chemistry at the Ludwig-Maximilians-University of Munich until 1992. After the move to the MRI, he was registered in the following two years as a specialist in laboratory medicine by the Bayerische Landesärztekammer and registered as specialist in Clinical Chemistry by the Deutsche Gesellschaft für Klinische Chemie (DGKL). Dr. Luppa got the appointment as associate professor at the TUM in 1997 and as “apl. Professor” in 2002. He still heads also a research laboratory for optical biosensor developments. Dr. Luppa’ s research interests span steroid biochemistry, biosensorics in autoantibody detection. This developed into the further focus on point-of-care testing (POCT) in the hospital sector. As chairman of the POCT section of the DGKL, he tries to evaluate the organizational and analytical-diagnostic challenges of this new technology in its impact on the healthcare system. He was awarded in 2017 by the AACC for “Outstanding Contributions in Point-of-Care Testing” and 2019 by the DGKL with the “Felix-Hoppe-Seyler Preis”. Dr. Luppa published 163 original peer-reviewed articles (listed in Pubmed, as of Jan 2026). Together with colleagues, he is the editor of the first German textbook on POCT (4th German edition 2025, 1st English edition 2018). Munich, January 21, 2026